Formula and Method for Maximum Allowable Blood Loss (MABL)
Maximum Allowable Blood Loss (MABL) is a perioperative planning estimate of how much blood a patient can lose before their hematocrit falls to a chosen minimum acceptable level, assuming the anesthesia or surgical team is replacing lost volume with crystalloid or colloid so total blood volume stays roughly constant (a process called isovolemic hemodilution). The most widely used version is Gross's formula: MABL = EBV × (Hi − Hf) / Hi, where EBV is the estimated blood volume in mL, Hi is the patient's starting hematocrit, and Hf is the lowest hematocrit still considered acceptable for that patient. This calculator also derives EBV from body weight and patient category, and expresses MABL as a percentage of total blood volume.
How the calculation works
First, the calculator converts weight to kilograms if needed, then multiplies it by an average blood volume factor (mL per kg) for the selected patient category to get the estimated blood volume: EBV = weight (kg) × mL/kg. It then applies Gross's formula using the starting hematocrit (Hi) and the minimum acceptable hematocrit (Hf) you specify: MABL = EBV × (Hi − Hf) / Hi. The same fractional drop, (Hi − Hf) / Hi × 100, is also shown as a percentage of blood volume so the result is easy to compare across patients of different sizes.
Typical blood volume factors and hematocrit targets
- Average blood volume by category: roughly 75 mL/kg for adult males, 65 mL/kg for adult females, 80 mL/kg for infants and children, 85 mL/kg for term neonates, and up to 96 mL/kg for premature neonates. These are population averages used for estimation, not measured values.
- Starting hematocrit (Hi): typically the patient's most recent preoperative hematocrit, commonly 36-46% in healthy adults.
- Minimum acceptable hematocrit (Hf): chosen by the clinical team based on the patient's cardiovascular reserve, comorbidities, and the type of surgery; commonly somewhere in the 21-30% range for otherwise healthy patients, but individualized case by case.
Clinical interpretation and limitations
MABL is an educational estimate, not a transfusion order or a substitute for professional medical judgment. It assumes steady, well-replaced volume loss and does not account for ongoing active bleeding rate, oxygen-carrying capacity needs, cardiac or pulmonary reserve, coagulation status, or symptoms of inadequate perfusion. The actual decision to transfuse blood products should always be made by the treating clinical team using real-time vital signs, laboratory trends, and institutional protocols — consult a qualified healthcare professional before applying this estimate to patient care.